The Cooper (STU:CP60) Change In Receivables : €0 Mil (TTM As of Apr. 2024)

View and export this data going back to 1983. Start your Free Trial

What is The Cooper Change In Receivables?

The Cooper's change in receivables for the quarter that ended in Apr. 2024 was €0 Mil. It means The Cooper's Accounts Receivable stayed the same from Jan. 2024 to Apr. 2024 .

The Cooper's change in receivables for the fiscal year that ended in Oct. 2023 was €-57 Mil. It means The Cooper's Accounts Receivable increased by €57 Mil from Oct. 2022 to Oct. 2023 .

The Cooper's Accounts Receivable for the quarter that ended in Apr. 2024 was €642 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. The Cooper's Days Sales Outstanding for the three months ended in Apr. 2024 was 66.67.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. The Cooper's liquidation value for the three months ended in Apr. 2024 was €-3,007 Mil.

The Cooper Change In Receivables Historical Data

The historical data trend for The Cooper's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Change In Receivables Chart

The Cooper Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Change In Receivables

Get a 7-Day Free Trial

-50.26

7.23

-65.08

-34.31

-57.01

The Cooper Quarterly Data
	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

The Cooper Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Apr. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

The Cooper (STU:CP60) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

The Cooper's Days Sales Outstanding for the quarter that ended in Apr. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	641.868	/	878.503	*	91
=	66.67

2. In Ben Graham's calculation of liquidation value, The Cooper's accounts receivable are only considered to be worth 75% of book value:

The Cooper's liquidation value for the quarter that ended in Apr. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	104.757	-	3954.942	+	0.75 * 641.868	+	0.5 * 722.673
=	-3,007

The Cooper Change In Receivables Related Terms

Thank you for viewing the detailed overview of The Cooper's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

The Cooper (STU:CP60) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (STU:CP60) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

COO:USA COO:Mexico C1OO34:Brazil

Address

6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583

Website

https://www.coopercos.com

The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

The Cooper (STU:CP60) Headlines

No Headlines